Results 11 to 20 of about 3,421,754 (284)

Hybrid Compounds as Anti-infective Agents [PDF]

open access: yesCurrent Topics in Medicinal Chemistry, 2017
Hybrid drugs are multi-target chimeric chemicals combining two or more drugs or pharmacophores covalently linked in a single molecule. In the field of anti-infective agents, they have been proposed as a possible solution to drug resistance issues, presumably having a broader spectrum of activity and less probability of eliciting high level resistance ...
Sbaraglini, Maria Laura, Talevi, Alan
openaire   +4 more sources

Editorial: Inspired by Nature: Towards Novel Anti-Infective Agents [PDF]

open access: yesFrontiers in Pharmacology, 2022
Ricardo J. Ferreira   +5 more
doaj   +2 more sources

Drugs Targeting Sirtuin 2 Exhibit Broad-Spectrum Anti-Infective Activity

open access: yesPharmaceuticals
Direct-acting anti-infective drugs target pathogen-coded gene products and are a highly successful therapeutic paradigm. However, they generally target a single pathogen or family of pathogens, and the targeted organisms can readily evolve resistance ...
Thomas Shenk   +2 more
doaj   +2 more sources

Lipid Nanoparticles Loaded with Farnesol or Geraniol to Enhance the Susceptibility of E. coli MCR-1 to Colistin

open access: yesPharmaceutics, 2021
Resistance to colistin, one of the antibiotics of last resort against multidrug-resistant Gram-negative bacteria, is increasingly reported. Notably, MCR plasmids discovered in 2015 have now been reported worldwide in humans.
Chantal Valcourt   +5 more
doaj   +1 more source

Comparison between Colistin Sulfate Dry Powder and Solution for Pulmonary Delivery

open access: yesPharmaceutics, 2020
To assess the difference in the fate of the antibiotic colistin (COLI) after its pulmonary delivery as a powder or a solution, we developed a COLI powder and evaluated the COLI pharmacokinetic properties in rats after pulmonary administration of the ...
Frédéric Tewes   +7 more
doaj   +1 more source

Emerging paradigms in anti-infective drug design. [PDF]

open access: yes, 2014
The need for new drugs to treat microbial infections is pressing. The great progress made in the middle part of the twentieth Century was followed by a period of relative inactivity as the medical needs relating to infectious disease in the wealthier ...
Croft, Simon L   +3 more
core   +1 more source

Evolution and Biological Evaluation of Matrinic Derivatives with Amantadine Fragments As New Anti-Influenza Virus Agents

open access: yesMolecules, 2019
A series of novel tricyclic matrinic derivatives with 11-adamantyl substitution were designed, synthesized, and evaluated for their activities against Influenza A H3N2 virus, based on the privileged structure strategy.
Tianyu Niu   +7 more
doaj   +1 more source

Anti-Infective Treatment and Resistance Is Rarely Problematic with Eye Infections

open access: yesAntibiotics, 2022
The treatment of eye infections is very different than treating other body infections that require systemic anti-infectives. Endophthalmitis, keratitis, conjunctivitis, and other ocular infections are treated with direct injection and with topical drops ...
Regis P. Kowalski   +3 more
doaj   +1 more source

Linking sustainable use policies to novel economic incentives to stimulate antibiotic research and development

open access: yesInfectious Disease Reports, 2017
There is now global recognition that antibiotic resistance is an emerging public health threat. Policy initiatives are underway to provide concrete suggestions for overcoming important obstacles in the fight against antibiotic resistance, like the ...
Ursula Theuretzbacher   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy